Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma.
Posch C, Cholewa BD, Vujic I, Sanlorenzo M, Ma J, Kim ST, Kleffel S, Schatton T, Rappersberger K, Gutteridge R, Ahmad N, Ortiz/Urda S.
Posch C, et al. Among authors: gutteridge r.
J Invest Dermatol. 2015 Oct;135(10):2475-2483. doi: 10.1038/jid.2015.198. Epub 2015 May 27.
J Invest Dermatol. 2015.
PMID: 26016894
Free PMC article.